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The incidence of esophageal squamous cell car-cinoma (SCC) shows marked variation, with half of all esophageal SCC in the world oc-
curring in China.1 Carcinosarcoma of the esophagus 
is regarded as a rare malignant neoplasm composed 
of both carcinomatous and sarcomatous elements. 
Case reports introducing the pathological character-
istics of this tumor have increased recently, and it is 
gradually becoming accepted that the spindle-shaped 
cells in the sarcomatous component are of squamous 
epithelial cell origin and that this category of tumor 
is one of the special types of SCC. However, there are 
no reports of these two types combined, so the true 
incidence and precise prognosis of carcinosarcoma 
remain unknown.2
In previous reports, there are no significant dif-
ferences in age, sex, symptoms, or location be-
tween the carcinosarcoma and SCC of esophagus. 
Carcinosarcoma had the following morphological 
characteristics: 75% cases were of the elevated type, 
with large tumor size in 80% of cases, the depth of 
invasion was limited to the esophageal wall, compared 
with the frequency of lymph node recurrence, hema-
togenous (lung and/or liver) metastasis was higher for 
carcinosarcoma. Although the three-year survival rate 
was higher for carcinosarcoma (62.8%), there was no 
Carcinosarcoma of the pleura and lung 
metastasized from a poorly differentiated 
squamous cell carcinoma of the esophagus
from the tri-service General hospital, taipei, taiwan 
correspondence: chien-Wen chen · tri-service General hospital, taipei, taiwan · ndmc.tw.tw@gmail.com · accepted for publication november 
2008
hematol oncol stem cell ther 2010; 3(1): 47-50
ChientWen Chen, KuantYu Chen, ChintJung Lin, WanntCherng Perng, JiatHong Chen
significant difference in the five-year survival rate be-
tween them.2 We present the first case of transforma-
tion of a poorly differentiated SCC of the esophagus 
into a “carcinosarcoma” of the pleura and lung.
CAsE
A 48-year-old man was admitted to our hospital 
with a 2-month history of progressive dysphagia and 
weight loss of 5 kilograms in 2 months. Past history 
included hepatitis C virus and alcohol-related cirrho-
sis of the liver complicated with esophageal varices, 
which were ligated 2 years previously. Splenomegaly, 
thrombocytopenia and coagulopathy had been noted 
for 5 years. He reported a 20 pack-year history of 
smoking, having stopped using tobacco one year pre-
viously. Physical examination revealed tumor marker 
levels that were all within normal limits: SCC anti-
gen, 1 ng/mL and carcinoembryonic antigen (CEA) 
3 ng/mL. Upper gastrointestinal series revealed a 
segmental filling defect about 9.5 cm in length with 
mucosa destruction over the esophagus at the level 
above the carina, consistent with esophageal carci-
noma. The CT scan of the chest showed a large, lobu-
lated soft-tissue mass about 6.4×3.3×3.3 cm over the 
esophagus, from a level near the thoracic inlet to a 
level about 0.5 cm above the carina. Enlarged nodes 
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in the surrounding region of the esophageal tumor 
were suggestive of esophageal carcinoma with cervi-
cal lymph nodal metastasis. Endoscopic examination 
revealed a ulcerative mass at 22 to 27 cm from the 
incisors. Analysis of the biopsy specimen showed the 
tumor to be a poorly differentiated SCC. On the ba-
sis of an imaging study and biopsy findings, a poorly 
differentiated SCC of the thoracic esophagus, upper 
third, T4N1M1a, stage IVa, was confirmed.
The patient underwent chemotherapy (weekly cis-
platin) and radiation therapy (66 Gy) for 2 months. 
After treatment, a follow-up CT scan of the chest 
revealed significant resolution. Because of progres-
sive dysphagia, he received a percutaneous esopha-
gogastrostomy, bur still choked easily when drinking 
liquids. He had been admitted to our hospital twice 
due to aspiration pneumonia. He received regular fol-
low-up at the outpatient department. The image did 
not reveal lung parenchyma mass or pleural effusion 
1-2 months before the last admission. 
Two weeks prior to the admission, progressive 
shortness of breath and nocturnal cough were noted. 
Physical examination revealed decreased breathing 
sounds over the left lung field. Chest x-ray showed 
massive left pleural effusion (Figure 1). A CT scan 
of the chest showed a huge lobulated soft-tissue 
density mass over the esophagus, from the cervical 
level to near the carina, with mediastinal extension. 
Lobulated soft-tissue density masses around 9 cm in 
size were in the left lung parenchyma and numerous 
soft-tissue density tumors were over the left pleura. 
There werre bilateral pleural effusions and multiple 
enlarged nodes in the surrounding region of the 
esophageal tumor and neck, and pulmonary, pleural 
and multiple lymph node metastases were highly sus-
pected (Figure 2).
Diagnostic sono-guiding pleural biopsy and tho-
racentesis revealed a malignant anaplastic tumor ac-
companied by a solid tumor nest with bizarre nuclei 
and prominent nucleoli. The tumor cells were immu-
nohistochemically positive for vimentin, but negative 
for cytokeratin (Figure 3). According to the histo-
pathological and immunohistochemical stain results, 
carcinosarcoma was diagnosed. Because of declining 
performance status, chemoradiation therapy was 
withdrawn and palliative therapy was given. He even-
tually died of disease progression under hospice care 
9 months after SCC of the thoracic esophagus was 
diagnosed and one month after carcinosarcoma of the 
pleura and lung were confirmed.
DIsCussIOn
Our patient had been diagnosed with primary poorly 
differentiated SCC of the esophagus and had re-
ceived concurrent chemoradiotherapy (CCRT) for 
2 months. He had developed secondary carcinosar-
coma of the pleura and lung 5 months later. Using 
the phrase ‘transformation of SCC of esophagus into 
a “carcinosarcoma” in a search of MEDLINE on the 
PubMed website, we found no cases of this type. 
The most widely accepted hypothesis on the his-
togenesis of carcinosarcoma is that it originates from 
stem cells, which are present in almost all tissues and 
may generate different cellular lineages by the multi-
step process of differentiation. The role of stem cells 
in tumorigenesis has been clearly demonstrated in a 
number of carcinogenic models.3-5 Recent studies have 
supported a “monoclonal hypothesis”, which proposes 
an origin from a single totipotential stem cell that dif-
ferentiates along distinct epithelial and mesenchymal 
pathways.6 Concordance of positive p53 staining in 
both the epithelial and sarcomatous components of 
carcinosarcomas has been adduced in support of the 
monoclonal hypothesis.7
Most cancers result from the interaction of genet-
ics and environment. Environmental factors could 
explain 95% of all cancer, and radiotherapy and che-
motherapy are the most established causes of second 
malignant neoplasm.8 The patient received CCRT, 
which may be an inducible factor for the transforma-
tion from SCC into carcinosarcoma. However, this 
was also a case of esophageal tumor: the initial bi-
opsy showed SCC and the lung metastasis showed Figure 1. Chest x-ray showing massive left pleural effusion.
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Figure 2. CT scan showing (a) no abnormal findings of lung and pleura in march 2008, (b) 2 months later, showing multiple soft tissue 
density masses over the left pleura and lung.
Figure 3. Pleural biopsy showing (a) the tumor consisted of a 
proliferation of malignant spindled cells and anaplastic tumor with 
bizarre nuclei and prominent nucleoli; (b) the tumor cells were 
ohistochemically positive for vimentin; (c) negative for cytokeratin.
carcinosarcoma. Although it may be SCC that trans-
formed to carcinosarcoma, the likely explanation is 
that this was a carcinosarcoma from the start. The 
initial biopsy was small and was interpreted as SCC. 
Carcinosarcoma would have been confirmed initially 
by the resection of the esophagus, but resection of the 
esophagus was not indicated in this case, which was 
in the terminal stages of esophageal cancer.
Several previous reports refer to a good progno-
sis with carcinosarcoma.9-13 However, the prognosis 
of carcinosarcoma at present is not as favorable as 
previously reported. Esophageal carcinosarcoma may 
become symptomatic earlier than SCC, thus aid-
ing detection and diagnosis, but it is not associated 
with a better long-term prognosis because of its rapid 
growth.14 Limited invasion, high resectability and a 
good prognosis with a 3-year survival rate were noted. 
On the other hand, the 5-year survival rate may be 
influenced by a relatively high possibility of hema-
togenous metastasis of the carcinosarcoma in the late 
period.2 The true incidence and prognosis of esopha-
geal carcinoma is still uncertain due to the rarity of 
reported cases. Our case of secondary carcinosarcoma 
had distinguishing characteristics, including a large 
recurrent esophagus tumor, adjacent lymph node me-
tastasis, and rapid hematogenous metastasis to the 
lung and pleura. In conclusion, we think this case is 
interesting because carcinosarcoma rarely arises from 
an SCC of the esophagus with progressive metastases 
to lung and pleura. To our knowledge, this is the first 
report of this nature.
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